Colorado Therapeutics is focused on developing xenogenic (sourced from different mammalian species) biologic tissue matrix products for a broad range of soft tissue reinforcement, regenerative, and vascular applications.
The Company is leveraging over 15 years of innovative and proprietary tissue processing technology to produce a superior biologic product that combines the benefits of currently available biologic and synthetic products.
Colorado Therapeutics’ devices are in development. No devices or other products are currently offered for sale by the company. Discussion of the technical features of products under development do not in any way constitute claims for clinical effectiveness or pledges of future performance.
Vice President: Eri Schauble
Please click here for Colorado Therapeutics job opportunities .